– USA, GA – Koning Corporation announced the addition of Angélica Fuentes to its Board of Directors.
“Angélica’s platform and work has always been about women’s choice. With her joining our board, we will give women everywhere the choice to avoid compression. We’re taking a major step forward for women’s health,” said CEO, Lutao Ning, Koning.
About Angélica Fuentes
Angélica Fuentes is a Mexican American businesswoman and investor recognized by Forbes Magazine as one of Mexico’s most powerful women. Throughout her career, Ms. Fuentes has sustained a strong commitment to organizations supporting the cause of women.
Angélica was appointed CEO of Grupo Imperial in 1992 at the age of 29. She quickly positioned the company as a top player in Northern Mexico’s energy sector. She served as President of the Mexican Natural Gas Association from 1996 to 2000 and the Business Energy Network of the Asia-Pacific Economic Cooperation Agreement from 2002 to 2004. From 2007 to 2015, she served as CEO of Grupo Omnilife-Angelissima-Chivas. Under her leadership, the company became one of the top 100 corporations in Mexico. In 2019, she founded Muvop, a microfinance institution that targets those who lack access to credits and provides an e-learning platform focused on personal empowerment and financial education.
“Koning’s technology produces high-contrast real 3D images of the breast with exceptional spatial resolution,” said Angélica Fuentes.
Ms. Fuentes is a founding member and the general of Poder Partners LLC, a group which manages investments in healthcare and impact investments.
About Koning
Koning is a global Health Technology company focused on improving the breast imaging industry with its patented Koning Breast CT. Koning’s vision is to create a revolution in medical imaging through advanced computed tomography technology that dramatically improves the way clinicians visualize and evaluate breast tissue. The KBCT is expected to optimize early disease detection, diagnosis, intervention, and treatment, and will improve survival rates for millions of patients worldwide.
For more information: https://www.koninghealth.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
